Literature DB >> 9836081

Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel disease.

L Camoglio1, A A Te Velde, A J Tigges, P K Das, S J Van Deventer.   

Abstract

Experimental data indicate that mucosal CD4+ T cells play an important role in the pathogenesis of inflammatory bowel disease (IBD). Based on the pattern of cytokine production, CD4+ T cells may be distinguished into two different phenotypes. Th1 responses are characterized by secretion of interleukin (IL)-2, tumor necrosis factor (TNF)-alpha, lymphotoxin, and interferon (IFN)-gamma and are associated with delayed-type hypersensitivity reactions, whereas Th2 responses, which are characterized by secretion of IL-4, IL-5, and IL-10, have been associated with humoral immune responses and allergy. To assess the number of IFN-alpha and IL-4 positive cells in IBD and normal intestinal specimens, frozen sections from intestinal specimens from 10 Crohn's disease (CD), 8 ulcerative colitis (UC), and 8 healthy controls were examined by immunohistochemistry. Monoclonal antibodies for CD3, CD8, IFN-gamma, and IL-4 were used. T-lymphocyte infiltration and cytokine expression by epithelial, lamina propria, and submucosal cells were scored on a four-point scale by two independent observers who were blinded for the clinical data. One-way analysis of variance (ANOVA) testing was used for statistical analysis. In intestinal specimens from IBD patients, the number of CD3+ cells was found increased in the lamina propria and, within the submucosa, this increase was significant (p < 0.001). In CD the number of lamina propria IFN-gamma positive cells was significantly increased as compared with controls (p < 0.002). In UC the number of both IFN-gamma and IL-4 producing cells in the lamina propria was not significantly increased as compared with controls. The present results confirm the existence of a Th1-biased pattern production in CD but not in UC.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9836081     DOI: 10.1002/ibd.3780040406

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  32 in total

1.  IL-10 secretion and sensitivity in normal human intestine and inflammatory bowel disease.

Authors:  C Gasche; S Bakos; C Dejaco; W Tillinger; S Zakeri; W Reinisch
Journal:  J Clin Immunol       Date:  2000-09       Impact factor: 8.317

2.  Cytokine profiles in peripheral blood of children and adults with Crohn disease.

Authors:  Seung Pak; Nina Holland; Elizabeth A Garnett; Elizabeth Mileti; Uma Mahadevan; Rachel Beckert; Bittoo Kanwar; Melvin B Heyman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-06       Impact factor: 2.839

3.  Emu oil increases colonic crypt depth in a rat model of ulcerative colitis.

Authors:  Suzanne M Abimosleh; Ruth J Lindsay; Ross N Butler; Adrian G Cummins; Gordon S Howarth
Journal:  Dig Dis Sci       Date:  2011-12-07       Impact factor: 3.199

4.  CCR4 is an up-regulated chemokine receptor of peripheral blood memory CD4+ T cells in Crohn's disease.

Authors:  Y Jo; T Matsumoto; S Yada; K Fujisawa; M Esaki; N Onai; K Matsushima; M Iida
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

5.  Cytokine regulation of OCTN2 expression and activity in small and large intestine.

Authors:  Mikihiro Fujiya; Yuhei Inaba; Mark W Musch; Shien Hu; Yutaka Kohgo; Eugene B Chang
Journal:  Inflamm Bowel Dis       Date:  2010-08-18       Impact factor: 5.325

6.  Chronic recurrent multifocal osteomyelitis associated with chronic inflammatory bowel disease in children.

Authors:  A Bousvaros; M Marcon; W Treem; P Waters; R Issenman; R Couper; R Burnell; A Rosenberg; E Rabinovich; B S Kirschner
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

7.  No association between the SOCS-1 -1478CA/del polymorphism and ulcerative colitis in Turkish subjects.

Authors:  Mustafa Hartavi; Selim Giray Nak; Barbaros Oral; Adem Deligönül
Journal:  Mol Biol Rep       Date:  2014-07-02       Impact factor: 2.316

Review 8.  Old and New Lymphocyte Players in Inflammatory Bowel Disease.

Authors:  Paolo Giuffrida; Gino Roberto Corazza; Antonio Di Sabatino
Journal:  Dig Dis Sci       Date:  2017-12-23       Impact factor: 3.199

9.  Histological and immunological features of appendix in patients with ulcerative colitis.

Authors:  Yukihiko Jo; Takayuki Matsumoto; Shinichiro Yada; Shotaro Nakamura; Takashi Yao; Masayuki Hotokezaka; Ryuichi Mibu; Mitsuo Iida
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

10.  The GPR55 antagonist CID16020046 protects against intestinal inflammation.

Authors:  A Stančić; K Jandl; C Hasenöhrl; F Reichmann; G Marsche; R Schuligoi; A Heinemann; M Storr; R Schicho
Journal:  Neurogastroenterol Motil       Date:  2015-07-30       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.